γδ T cell-derived IL-17A aggravates experimental epidermolysis bullosa acquisita in response to IL-1β
Epidermolysis bullosa acquisita (EBA) is a mucocutaneous autoimmune blistering disorder mediated by autoantibodies against type VII collagen and subsequent